5-fluorouracil and curcuminoids extract from Curcuma longa L. loaded into nanohydroxyapatite as a drug delivery carrier for SKOV-3 and HepG2 cancer cells treatment
Source abstract
Abstract
Nie dotyczy
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Bone Tissue Engineering Materials · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Biocompatibility of engineered nanoparticles for drug delivery10.1016/j.jconrel.2012.12.013 ↗
2. Biocompatible nanomaterials in food science, technology, and nutrient drug delivery: recent developments and applications10.3389/fnut.2021.778155 ↗
3. Nanoscale hydroxyapatite particles for bone tissue engineering10.1016/j.actbio.2011.03.019 ↗
4. Hydroxyapatite-Poly(Vinyl alcohol) core-shell nanoparticles for dual delivery of methotrexate and gemcitabine for bone cancer treatment10.1016/j.jddst.2019.03.041 ↗
5. Sorption studies of tetracycline antibiotics on hydroxyapatite (001) surface—a first-principles insight
6. Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite
7. Synthesis of hydroxyapatite for biomedical applications10.1016/j.cis.2017.04.007 ↗
8. Preparation and antimicrobial activity of the porous hydroxyapatite nanoceramics10.1016/j.jallcom.2018.03.162 ↗
9. Preparation and preliminary evaluation of bio-nanocomposites based on hydroxyapatites with antibacterial properties against anaerobic bacteria10.1016/j.msec.2019.110295 ↗
10. Characterization and in vivo biocompatibility analysis of synthetic hydroxyapatite compounds associated with magnetite nanoparticles for a drug delivery system in osteomyelitis treatment
11. Sequential dual-drug delivery of BMP-2 and alendronate from hydroxyapatite-collagen scaffolds for enhanced bone regeneration
12. Polyurethane electrospun membranes with hydroxyapatite-vancomycin for potential application in bone tissue engineering and drug delivery10.1002/app.51893 ↗
13. Biodegradable drug-loaded hydroxyapatite nanotherapeutic agent for targeted drug release in tumors10.1021/acsami.7b19281 ↗
14. Hybrid polymeric systems of mesoporous silica/hydroxyapatite nanoparticles applied as antitumor drug delivery platform10.1111/ijac.13231 ↗
15. Adsorption beahavior of drug on hydroxyapatite with different morphologies: a combined experimental and molecular dynamics simulation study10.1016/j.ceramint.2019.06.068 ↗
16. Effects of physico-chemical properties of ions-doped hydroxyapatite on adsorption and release performance of doxorubicin as a model anticancer drug10.1016/j.matchemphys.2021.125440 ↗
17. Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells10.1016/j.ijpharm.2013.02.002 ↗
18. The efficacy of methotrexate-impregnated hydroxyapatite composites on human mammary carcinoma cells10.1177/230949900701500113 ↗
19. Synergistic effect of toceranib and nanohydroxyapatite as a drug delivery platform—physicochemical properties and in vitro studies on mastocytoma cells10.3390/ijms23041944 ↗
20. Layered nanohydroxyapatite as a novel nanocarrier for controlled delivery of 5-fluorouracil10.1016/j.ijpharm.2016.09.004 ↗
21. Effect of nano-hydroxyapatite and ozone on approximal initial caries: a randomized clinical trial10.1038/s41598-020-67885-8 ↗
22. Novel fabrication of marizomib-loaded chitosan-coated hydroxyapatite nanocarriers as a promising system for effective treatment of ovarian cancer mater
23. Hydroxyapatite biobased materials for treatment and diagnosis of cancer
24. Spray-dried hydroxyapatite-5-Fluorouracil granules as a chemotherapeutic delivery system10.1016/j.ceramint.2008.01.012 ↗
25. Synthesis of different sized and porous hydroxyapatite nanorods without organic modifiers and their 5-fluorouracil release performance10.1016/j.msec.2015.07.008 ↗
26. Tseng
27. Doxorubicin-intercalated nano-hydroxyapatite drug-delivery system for liver cancer: an animal model10.1016/j.ceramint.2013.05.074 ↗
28. ROS-induced HepG2 cell death from hyperthermia using magnetic hydroxyapatite nanoparticles
29. Novel method to improve the anticancer activity of natural-based hydroxyapatite against the liver cancer cell line HepG2 using mesoporous magnesia as a micro-carrier10.3390/molecules22121947 ↗
30. Label-free determination of liver cancer stages using surface-enhanced Raman scattering coupled with preferential adsorption of hydroxyapatite microspheres10.1039/D1AY00946J ↗
31. M. Tantawy, A. Wilson, A. Beeghly-Fadiel, F. Yull, J. Gore, R. Alvarez, M. Crispens, J. O. McIntyre, Tumor Extracellular Hydroxyapatite: a Potential Biomarker for Imaging Ovarian Cancer, Gynecol. Oncol., 162(202), 318-332 https://doi.org/10.1016/S0090-8258(21)01255-5.10.1016/S0090-8258(21)01255-5 ↗
32. Potential role of hydroxyapatite nanocrystalline for early diagnostics of ovarian cancer10.3390/diagnostics11101741 ↗
33. Formulation and evaluation ofAalginate-gelatin hydrogel scaffolds loaded with zinc-doped hydroxyapatite and 5-fluorouracil
34. Encapsulation of anticancer drug copper bis(8-hydroxyquinoline) in hydroxyapatite for pH-sensitive targeted delivery and slow release10.1016/j.msec.2016.10.010 ↗
35. Biodegradable drug-loaded hydroxyapatite nanotherapeutic agent for targeted drug release in tumors10.1021/acsami.7b19281 ↗
36. Treatment of refractory ovarian cancer with 5-fluorouracil and leucovorin10.1006/gyno.1996.0134 ↗
37. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy10.1111/j.1349-7006.2008.01065.x ↗
38. 5-Fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information10.1186/s12967-022-03423-6 ↗
39. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways
40. Recent studies of 5-fluorouracil resistance in pancreatic cancer10.3748/wjg.v20.i42.15682 ↗
41. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil10.1016/S0959-8049(96)00324-3 ↗
42. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting10.1016/j.apsb.2014.12.001 ↗
43. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting10.1016/j.ijpharm.2010.11.025 ↗
44. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients10.18632/oncotarget.24148 ↗
45. 5-fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING10.15252/embj.2020106065 ↗
46. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA10.1016/S0026-895X(25)09507-0 ↗
47. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity10.1016/j.clpt.2006.06.007 ↗
48. Therapeutic drug monitoring of 5-fluorouracil10.1007/s00280-016-3054-2 ↗
49. The combination of curcumin and 5-fluorouracil in cancer therapy10.1007/s12272-017-0979-x ↗
50. Optimization extraction and purification of biological activity curcumin from Curcuma longa L by high-performance counter-current chromatography10.1002/jssc.201901174 ↗
51. Solubilization and extraction of curcumin from Curcuma longa using green, sustainable, and food-approved surfactant-free microemulsions10.1016/j.foodchem.2020.127660 ↗
52. Curcuminoid content of Curcuma longa L. And Curcuma xanthorrhiza rhizome based on drying method with NMR and HPLC-UVD
53. Curcumin isolation, synthesis and characterization of curcumin isoxazole derivative compound
54. Comparative biochemistry and physiology, Part C antioxidant activity of di ff erent species and varieties of turmeric (Curcuma spp): isolation of active compounds
55. Curcumin Based Nanomedicines as e Ffi Cient Nanoplatform for Treatment of Cancer : new Developments in Reversing Cancer Drug Resistance, Rapid Internalization, and Improved Anticancer Efficacy10.1016/j.tifs.2018.07.026 ↗
56. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy
57. Development of turmeric oil—loaded chitosan/alginate nanocapsules for cytotoxicity enhancement against breast cancer10.3390/polym14091835 ↗
58. Simultaneous quantification of three curcuminoids and three volatile components of Curcuma longa using pressurized liquid extraction and high-performance liquid chromatography10.3390/molecules23071568 ↗
59. Curcuma longa L. Rhizome extract as a poly(vinyl chloride)/graphene nanocomposite green modifier10.3390/molecules27228081 ↗
60. Comprehensive review on the therapeutic potential of Curcuma longa linn. In relation to its major active constituent curcumin10.3389/fphar.2022.820806 ↗
61. Analysis of volatile constituents in Curcuma species, viz. C. Aeruginosa, C. Zedoaria, and C. Longa, from Nepal10.3390/plants11151932 ↗
62. Biological activities of zingiber officinale roscoe essential oil against Fusarium spp.: a minireview of a promising tool for biocontrol10.3390/agronomy12051168 ↗
63. Superior bioavailability of a novel curcumin formulation in healthy humans under fasting conditions10.1007/s12325-022-02081-w ↗
64. Chemical compositions, antioxidative, antimicrobial, anti-inflammatory and antitumor activities of Curcuma aromatica Salisb. essential oils10.1016/j.indcrop.2017.05.058 ↗
65. The essential medicinal chemistry of curcumin10.1021/acs.jmedchem.6b00975 ↗
66. Curcumin: from ancient medicine to current clinical trials10.1007/s00018-008-7452-4 ↗
67. The therapeutic potential of curcumin: a review of clinical trials10.1016/j.ejmech.2018.12.016 ↗
68. Chemical analysis of the Chinese herbal medicine turmeric (Curcuma longa L.)10.2174/157341210793292356 ↗
69. Analysis of curcuminoids and volatile components in 160 batches of turmeric samples in China by high-performance liquid chromatography and gas chromatography mass spectrometry
70. Heavy metal removal from aqueous systems using hydroxyapatite nanocrystals derived from clam shells10.1039/C9RA04198B ↗
71. On the formation of hydroxyapatite nano crystals prepared using cationic surfactant10.1590/1516-1439.298014 ↗
72. Curcumin-encased hydroxyapatite nanoparticles as novel biomaterials for antimicrobial, antioxidant and anticancer applications: a perspective of nano-based drug delivery
73. Zirconium doped hydroxyapatite as a potential design for lung therapy10.1016/j.ceramint.2021.06.219 ↗
74. Hierarchical hollow hydroxyapatite microspheres: microwave-assisted rapid synthesis by using pyridoxal-5′-phosphate as a phosphorus source and application in drug delivery10.1002/asia.201300142 ↗
75. Synthesis and characterization of hydroxyapatite and composite based on it with collagen/alginate10.1007/s11696-021-01841-2 ↗
76. Structural, morphological and electrical properties of new type Dy doped Ca6-xNa2Y2(SiO4)6(OH)2 hydroxyapatite compound synthesized by Co – precipitation method10.1007/s10832-021-00274-3 ↗
77. Green synthesis of hydroxyapatite nanoparticles from wrightia tinctoria and its antibacterial activity10.1007/s12668-022-01012-x ↗
78. Influence of spray-dried hydroxyapatite-5-fluorouracil granules on cell lines derived from tissues of mesenchymal origin10.3390/molecules13112729 ↗
79. Synthesis of mesoporous graphite functionalized by nitrogen for efficient removal of safranin dye utilizing rice husk ash; equilibrium studies and response surface optimization10.1007/s10904-017-0726-2 ↗
80. Treatment of Cd2+ and Cu2+ ions using modified apatite ore
81. Experimental and theoretical studies of the adsorption of Cu and Ni ions from wastewater by hydroxyapatite derived from eggshells
82. Influence of Li+ ions on the physicochemical properties of nanocrystalline calcium–strontium hydroxyapatite doped with Eu3+ ions10.1039/C9NJ03003D ↗
83. FTIR and XRD evaluation of carbonated hydroxyapatite powders synthesized by wet methods10.1016/j.molstruc.2004.11.078 ↗
84. A novel hydroxyapatite-hardystonite nanocomposite ceramic10.1016/j.ceramint.2015.01.033 ↗
85. Nam · 2018 · vol. 56 · 672
86. Electrodeposition of hydroxyapatite/functionalized carbon nanotubes (HAp/fCNTs) coatings on the surface of 316L stainless steel10.15625/2525-2518/55/6/9153 ↗
87. Synthesis and characterization of a lamellar hydroxyapatite/DNA nanohybrid10.1016/j.matchemphys.2010.12.060 ↗
88. The stability, sustained release and cellular antioxidant activity of curcumin nanoliposomes10.3390/molecules200814293 ↗
89. Synthesis and characterization of some ternary metal complexes of curcumin with 1,10-phenanthroline and their anticancer applications10.3329/jsr.v6i3.18750 ↗
90. 5-Florouracil-Loaded poly(lactic acid)-poly(caprolactone) hybrid scaffold: potential chemotherapeutic implant10.1002/jbm.a.34932 ↗
91. Preparation of 5-Fluorouracil/β-Cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties10.1021/ie100990z ↗
92. The inhibition of lamellar hydroxyapatite and lamellar magnetic hydroxyapatite on the migration and adhesion of breast cancer cells10.1007/s10856-013-5126-8 ↗
93. Rajapakse · 2021
94. Physico-chemical characterization of water-soluble pectic extracts from Rosa damascena, Calendula officinalis and Matricaria chamomilla wastes10.1016/j.foodhyd.2016.06.006 ↗
95. Factorial designed 5-fluorouracil-loaded microsponges and calcium pectinate beads plugged in hydroxypropyl methylcellulose capsules for colorectal cancer10.4103/2230-973X.167688 ↗
96. Study on the surface energies and dispersibility of graphene oxide and its derivatives10.1007/s10853-015-8934-z ↗
97. Roll-to-Roll-Compatible, flexible, transparent electrodes based on self-nanoembedded Cu nanowires using intense pulsed light irradiation10.1039/C6NR00444J ↗
98. Screening lactic acid bacteria strains with ability to bind di-n-butyl phthalate via turbiscan technique. Antonie van Leeuwenhoek
99. Dispersion stabilities of multi-layer graphene-coated copper prepared by electrical wire-explosion method10.1166/jnn.2016.13495 ↗
100. Application of turbiscan in the homoaggregation and heteroaggregation of copper nanoparticles10.1016/j.colsurfa.2017.09.015 ↗